Cilengitide in Treating Patients With Metastatic Prostate Cancer

Clinical trial NCT00103337 · COMPLETED

Trial details

NCT number: NCT00103337
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Prostate Cancer Stage IV Prostate Cancer

Start date: 2005-01-01
Primary completion: 2007-10-01
Enrollment: 106

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.